Sakr WA - Search Results

1

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Al-Sarraf M, et al. Among authors: sakr wa. J Clin Oncol. 1998 Apr;16(4):1310-7. doi: 10.1200/JCO.1998.16.4.1310. J Clin Oncol. 1998. PMID: 9552031 Corrected and republished. Clinical Trial.

2

Cellular DNA content parameters as prognostic indicators in human astrocytomas.

El-Rayes BF, Norton CS, Sakr W, Maciorowski Z, Smith D, Pietraszkiewicz H, Del Mar Alonso M, Ensley JF. El-Rayes BF, et al. J Neurooncol. 2005 Jan;71(2):85-9. doi: 10.1007/s11060-004-6044-x. J Neurooncol. 2005. PMID: 15690121

3

Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.

Agrawal A, Moon J, Davis RK, Sakr WA, Giri SP, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE; Southwest Oncology Group. Agrawal A, et al. Among authors: sakr wa. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1044-50. doi: 10.1001/archotol.133.10.1044. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17938330 Clinical Trial.

4

Pseudoaneuploid subpopulations detected in normal upper aerodigestive tract mucosa consistent with physiological apoptosis in normally differentiating squamous mucosa.

El-Rayes BF, Korkmaz H, Maciorowski Z, Sakr W, Jacobs JR, Ensley JF. El-Rayes BF, et al. Otolaryngol Head Neck Surg. 2004 Nov;131(5):633-8. doi: 10.1016/j.otohns.2004.04.036. Otolaryngol Head Neck Surg. 2004. PMID: 15523439

5

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM. Hussain M, et al. J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6. J Clin Oncol. 2018. PMID: 29624463 Free PMC article. Clinical Trial.

6

Clinical significance of poor CD3 response in head and neck cancer.

Shibuya TY, Nugyen N, McLaren CE, Li KT, Wei WZ, Kim S, Yoo GH, Rogowski A, Ensley J, Sakr W. Shibuya TY, et al. Clin Cancer Res. 2002 Mar;8(3):745-51. Clin Cancer Res. 2002. PMID: 11895904

7

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

Hussain M, Tangen CM, Lara PN Jr, Vaishampayan UN, Petrylak DP, Colevas AD, Sakr WA, Crawford ED; Southwest Oncology Group. Hussain M, et al. Among authors: sakr wa. J Clin Oncol. 2005 Dec 1;23(34):8724-9. doi: 10.1200/JCO.2005.02.4448. J Clin Oncol. 2005. PMID: 16314632 Clinical Trial.

8

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.

Dorff TB, Flaig TW, Tangen CM, Hussain MH, Swanson GP, Wood DP Jr, Sakr WA, Dawson NA, Haas NB, Crawford ED, Vogelzang NJ, Thompson IM, Glode LM. Dorff TB, et al. Among authors: sakr wa. J Clin Oncol. 2011 May 20;29(15):2040-5. doi: 10.1200/JCO.2010.32.2776. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502546 Free PMC article. Clinical Trial.

9

Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.

Jimenez RE, Hussain M, Bianco FJ Jr, Vaishampayan U, Tabazcka P, Sakr WA, Pontes JE, Wood DP Jr, Grignon DJ. Jimenez RE, et al. Among authors: sakr wa. Clin Cancer Res. 2001 Aug;7(8):2440-7. Clin Cancer Res. 2001. PMID: 11489824

10

Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy.

Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr. Bianco FJ Jr, et al. Among authors: sakr wa. Urol Oncol. 2004 Jul-Aug;22(4):290-4. doi: 10.1016/S1078-1439(03)00144-3. Urol Oncol. 2004. PMID: 15283885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page